Spravato® provides relief for patients with treatment-resistant depression (TRD) and has also shown promise in easing co-occurring anxiety symptoms. While it is FDA-approved specifically for TRD, clinical experience and research show it can significantly reduce anxiety in patients struggling with both depression and anxiety.
At Bristol Health, we design treatment plans tailored to your needs, and every Spravato® session is carefully monitored by our experienced team. With compassionate guidance, effective oversight, and ongoing support, we help you move toward lasting relief and a better quality of life.
Anxiety and depression often occur together, creating a cycle that can make recovery more challenging. For many people living with TRD, symptoms of anxiety, such as racing thoughts, restlessness, or even panic, intensify the weight of depression.
When both conditions are present, they can feed into each other. Anxiety may heighten feelings of hopelessness, while depression can make it harder to cope with anxious thoughts and fears. Therefore, treating depression alone is often not enough. Addressing anxiety alongside depression is essential for full recovery and long-term emotional well-being.
Spravato® nasal spray contains esketamine, a derivative of ketamine, and works differently from standard antidepressants. Most antidepressants focus on serotonin, dopamine, or norepinephrine. Spravato®, on the other hand, targets the N-methyl-D-aspartate (NMDA) receptor in the brain’s glutamate system, a key pathway involved in mood regulation and communication between brain cells.
By temporarily blocking NMDA receptors, esketamine stimulates a cascade of changes in brain chemistry that can help:
Since the glutamate system also influences anxiety, patients with TRD who also experience anxiety may notice significant relief in both areas. This dual benefit makes Spravato® an innovative option for broader emotional well-being.
Many people living with treatment-resistant depression also struggle with severe anxiety symptoms, making recovery even more challenging. While Spravato® is FDA-approved for TRD and not for generalized anxiety disorder (GAD), clinical experience suggests that it may ease anxiety symptoms when they occur alongside depression.
This study suggests that esketamine is effective for patients with treatment-resistant depression, whether or not they also have anxiety. In fact, no significant difference in outcomes between patients with and without comorbid anxiety was found, meaning Spravato® may provide meaningful relief across both groups.
At Bristol Health, our team carefully evaluates whether Spravato® may be part of your treatment plan, always prioritizing your safety, comfort, and long-term emotional well-being.
Traditional treatments for anxiety typically include selective serotonin reuptake inhibitors (SSRIs), benzodiazepines, and psychotherapy. SSRIs are often effective but can take weeks to months before patients notice improvements. Benzodiazepines provide rapid relief, but they are usually recommended only for short-term use. Therapy, such as cognitive behavioral therapy (CBT), remains a cornerstone of care and is highly effective, especially when combined with medication.
By targeting the brain’s glutamate system, Spravato® provides faster symptom relief, often within hours or days, making it a valuable option when anxiety symptoms are co-occurring with depression. Another advantage is that Spravato® does not require daily dosing; treatments are administered in a certified medical setting, reducing the burden of daily medication management. Moreover, our care team monitors for possible side effects such as dissociation or elevated blood pressure.
After each session at Bristol Health, you remain under observation for at least two hours. This ensures that treatment remains both effective and safe, while being tailored to your individual needs. Our experienced team develops personalized treatment plans that fit your health goals and lifestyle. From your first consultation through ongoing care, we prioritize safety, comfort, and long-term mental wellness.
Spravato® offers benefits that go beyond easing depressive symptoms, supporting patients in achieving overall emotional well-being. Key advantages include:
Spravato® offers a promising, innovative option to provide relief from depressive and co-occurring anxiety symptoms while enhancing overall mood. Its convenient nasal spray formulation, combined with a supervised, personalized treatment plan, supports emotional well-being and helps improve quality of life.
To learn more about how Spravato® can help you, please call us at (801) 903-5903 or request an appointment online. Our compassionate team is here to help you take the first step toward improved mental health and well-being.
If you are struggling and need someone to talk to right now, the resources below provide free and confidential assistance 24/7:
Suicide & Crisis Lifeline: 988
https://988lifeline.org/
Website Design & SEO by Numana Digital
